Chinese Japanese Germany Korea

Granisetron hydrochloride

Outline of Granisetron hydrochloride Domestic Market Analysis Instructions Chemical Properties Uses
Granisetron hydrochloride
Granisetron hydrochloride structure
Chemical Name:
Granisetron hydrochloride
Kitryl;KYTRIL;BRL-43694A;Gransetron HCl;GRANISETRON HCL;GranisetronBase;midehydrochloride;GranisetronHclFda;endo-monohydrochlorid;endo-monohydrochloride
Molecular Formula:
Formula Weight:
MOL File:

Granisetron hydrochloride Properties

Melting point:
storage temp. 
Room temp
H2O: >10mg/mL
white to off-white
CAS DataBase Reference
107007-99-8(CAS DataBase Reference)
  • Risk and Safety Statements
Signal word  Warning
Hazard statements  H302
Precautionary statements  P301+P312+P330
Hazard Codes  Xn,Xi
Risk Statements  22-62-37/38-36/37/38-36
Safety Statements  26-36-37-24/25
WGK Germany  3
RTECS  NK7882200
HS Code  29399990

Granisetron hydrochloride price More Price(9)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich G3796 Granisetron hydrochloride ≥98% (HPLC), solid 107007-99-8 10mg $118 2019-12-02 Buy
Sigma-Aldrich 1298106 Granisetron hydrochloride United States Pharmacopeia (USP) Reference Standard 107007-99-8 150mg $784 2019-12-02 Buy
TCI Chemical G0401 Granisetron Hydrochloride >98.0%(HPLC)(T) 107007-99-8 200mg $54 2019-12-02 Buy
TCI Chemical G0401 Granisetron Hydrochloride >98.0%(HPLC)(T) 107007-99-8 1g $187 2019-12-02 Buy
Cayman Chemical 21239 Granisetron (hydrochloride) ≥98% 107007-99-8 1g $338 2018-11-19 Buy

Granisetron hydrochloride Chemical Properties,Uses,Production

Outline of Granisetron hydrochloride

Granisetron hydrochloride was originally developed by the British Beecham company in the mid-1980s. At 1991, the merged Smithkline-Beecham (SB) Company had pushed for the first time of 3 mg of injection Kytri1 to the market in South Africa. To date, including 1 mg of oral tablets, 1mg of injections, granisetron hydrochloride has already entered into market in United States, Britain, France, Japan, Germany, Italy and other more than forty countries and regions around the world. When the Smithkline-Beecham (SB) Company was merged with Glaxo Company, it transferred this product to the Roche Company.
Foreign research data has shown that granisetron hydrochloride has a high selectivity to receptor. Its affinity to 5-HT3 receptor is 4000 to 10000 time as high as its affinity to other receptors, such as 5-HT1, 5-HT2, dopamine D1, D1, histamine H1, benzodiazepine and opioid receptor. For comparison, the difference for ondansetron is only about 1,000 times. For the test of its prevention of cisplatin-induced emesis in ferrets, the antiemetic rates in the three dose groups of granisetron hydrochloride 2 × 0.005,2 × 0.05 and 2 × 0.5mg/kg (iv) were 93%, 96% and 100 %, respectively while for ondansetron in 2 × 2.5mg/kg, this value was 89%, demonstrating that granisetron hydrochloride exhibited a at least five times stronger efficacy of anti-emetic than ondansetron. Toxicity studies suggest that granisetron hydrochloride can achieve very excellent antiemetic effect even in small dose with only minor side effects. However, there may be sth abnormal occurring in cardiovascular system upon large doses. Since the recommended clinical dose of granisetron hydrochloride is small (3mg/d), which is only 1/25 (<1 mg/kg) of the lowest dose used in animal studies, therefore, clinical application of it is very safe. Pharmacokinetic study has shown that granisetron hydrochloride has a half-life (t1/2) of 9 h in the body of patient while this value is 4 h at healthy people, 7.7 h in elderly people and 4.9h in young people. Granisetron hydrochloride is mainly metabolized in the liver and can be excreted through the feces and urine in the form of 7-hydroxy granisetron hydrochloride and other forms of metabolic product. For patients of liver damage or liver metastases, they have reduced plasma clearance rate with the scavenging rate upon renal insufficiency being 1/4 of the normal case. It has been observed of high first pass metabolism upon oral administration with the absolute bioavailability being 60%.

Domestic Market Analysis

1993, China has approved of the import of the Kytri1 injection (3 mg/ 3 mL) of British SB company, Registration No: X930279, and has allowed for in clinical trials. In 1994, the China-US Tianjin Smith Kline Pharmaceutical Co., Ltd. had used imported raw materials processing method for production of the injection of the 3mg granisetron hydrochloride and had obtained the approval of the Ministry of Health: (94) health medicine approved: J-10 number (fourth class) with the trade name being "Kay Reiter. " Currently there are a number of domestic manufacturers having their products enter into market with the number of manufacture which makes formulation being up to dozen, see Annex I for details.
China has a large population with the annual number of newly identified cancer patients being more than 1.6 million. The nausea and vomiting induced by chemotherapy and radiotherapy-induced have been one of the serious side effects that doctors and patients worry of. Therefore, new antiemetics are in urgent demand. Currently, ondansetron class of drugs has occupied most of the market antiemetic including ondansetron (ShufuLing), granisetron hydrochloride (Kytril) and tropisetron (Oubiting), wherein the ondansetron and granisetron has been accumulated of large number of clinical application experience with good response from the doctors and has played positive role on improving the domestic situation of the treatment of chemotherapy vomiting. With the localization of products, the decreasing price and the increasing income level of people, antiemetics market will be certainly greatly improved. In this case, granisetron hydrochloride, as the secondary antiemetic drug entering into market, will certainly have good market prospects.
The above information is edited by the chemicalbook of Dai Xiongfeng.


[Character]it is colorless or nearly colorless liquid clarity.
[Toxicology]This product is a highly selective 5-HT3 receptor antagonist and has excellent preventive and therapeutic effect on treating nausea and vomiting induced by radiotherapy, chemotherapy and surgery. Radiotherapy, chemotherapy and surgery and other factors can cause enterochromaffin cells to release 5-HT; 5-HT can activate the 5-HT3 receptors in central nerve or vagus nerve and cause vomiting reflex. The mechanism of this product in controlling nausea and vomiting is through antagonizing the 5-HT3 receptor in the central chemosensory area and peripheral vagus nerve terminal, further suppressing the nausea and vomiting. This product has high selectivity and no side effects such as extrapyramidal reactions, excessive sedation and so on.
[Indications]it is suitable for the treatment of nausea and vomiting induced by radiation therapy and cytotoxic drug.
[Dosage and usage amount]intravenous drip. Recommended dosage for adults is usually 3 mg. Administer it intravenously 30 minutes prior to chemotherapy. Most patients only need to be administered once with the prevention action against nausea and vomiting being more than 24 hours. The number of doses can be increased by 1-2 times if necessary, but the maximum daily dose should not exceed 9 mg and the infusion time should not be less than 5 minutes.
[Pharmacokinetics]healthy volunteers, after intravenous injection of this product for 20 or 40 μg/kg, the average peak plasma concentration was 13.7 and 42.8μg/L, the plasma elimination half-life is approximately 3.1-5.9 hours. This product is widely distributed in the body with serum protein binding rate being about 65%. Most of them are rapidly metabolized with the major metabolic pathway being N-dealkylation and conjugation after aromatic oxidation. This product is excreted through the feces and urine.

Chemical Properties

It is white or yellowish white crystalline powder and is odorless. It is easily soluble in water but hardly soluble in methanol, extremely hardly to be dissolved in ethanol and almost insoluble in ether. It has a melting point of 290-292 ℃. For acute toxicity LD50, female mice, male and female rats (mg/kg): 17, 25, 14, 16, respectively. Intravenous injection.


It is the selective antagonist of the 5-serotonin 3 (5-HT3) in peripheral and central nervous system.


Granisetron hydrochloride is the second selective 5HT-3-antagonist approved for the management of nausea and vomiting induced by cancer chemotherapy.Like ondansetron, granisetron hydrochloride is superior to metoclopramide in both efficacy and side effect profile. The compound appears to be effective both as a prophylactic agent and in blocking vomiting once started.

Chemical Properties

White to Off-White Crystalline Sold


SmithKline Beecham (United Kingdom)




A specific serotonin (5HT3) receptor antagonist. Used as an antiemetic. Granisetron HCl is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemothera py. Its main effect is to reduce the activity of the vagus nerve. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarini c receptor

brand name

Kytril (Roche).

Biological Activity

5-HT 3 receptor antagonist that possesses potent antiemetic activity.

Veterinary Drugs and Treatments

Granisetron is an alternative to other 5-HT3 receptor antagonists (e.g., ondansetron or dolasetron) for the treatment of severe vomiting or prophylaxis before administering antineoplastic drugs such as cisplatin that can cause severe vomiting.

Granisetron hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

Granisetron hydrochloride Suppliers

Global( 340)Suppliers
Supplier Tel Fax Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
+86-571-85864795 China 19927 60
Henan DaKen Chemical CO.,LTD.
+86-371-55531817 CHINA 21829 58
Beijing Cooperate Pharmaceutical Co.,Ltd.
+86-10-60279497 +86(0)15646567669
+86-10-60279497 CHINA 1817 55
Henan Tianfu Chemical Co.,Ltd.
0371-55170693 CHINA 22626 55
020-81716319 CHINA 2552 55
Shanghai Yingrui Biopharma Co., Ltd.
+86-21-34979012 CHINA 739 60
career henan chemical co
+86-371-86658258 CHINA 30050 58
Jinan Jianfeng Chemical Co., Ltd
15562555968 CHINA 301 58
Chemwill Asia Co.,Ltd.
86-21-51861608;;; CHINA 23977 58
Xiamen AmoyChem Co., Ltd
+86 592-605 1114 CHINA 6372 58

View Lastest Price from Granisetron hydrochloride manufacturers

Image Release date Product Price Min. Order Purity Supply Ability Manufacturer
2020-05-06 Granisetron hydrochloride
US $1.00-1.00 / KG 1g 99% 50tons Shaanxi Dideu Medichem Co. Ltd
2018-07-26 Granisetron hydrochloride
US $100.00 / KG 1KG 99% Customized career henan chemical co

107007-99-8(Granisetron hydrochloride)Related Search:

Copyright 2017 © ChemicalBook. All rights reserved